Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story
April 24, 2015 at 08:33 AM EDT
In a report published Friday, Morgan Stanley analysts maintained an Overweight rating on Gilead Sciences, Inc. (NASDAQ: GILD). Headline ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.